Skip to main content
Fig. 2 | Reproductive Biology and Endocrinology

Fig. 2

From: Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients

Fig. 2

Predictive accuracy of different models. A Area under the receiver operating characteristic curves (AUCs) of FBG, PCOS and MetS respectively for the prediction of time to CR in fertility-sparing treatment patients; B Area under the receiver operating characteristic curves (AUCs) of FBG + PCOS and FBG + PCOS + MetS for the prediction of time to CR. C Decision curve analysis (DCA) of FBG + PCOS and FBG + PCOS + MetS for the prediction of time to CR in fertility-sparing treatment patients. FBG: fasting blood glucose; PCOS: polycystic ovarian syndrome; MetS: metabolic syndrome

Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us